Most users in the thread strongly favor tirzepatide as the next option after poor results with retatrutide, citing better appetite control and fewer complaints. Individual responses to retatrutide vary widely, with some blaming inconsistent product quality or prior high-dose tirzepatide use for weak effects. Several people report good outcomes stacking low-dose tirzepatide with retatrutide or using tirzepatide alone for modest weight loss goals.
What this discussion establishesWhether retatrutide underperformance stems mainly from bad batches or from individual biology and prior GLP-1 exposure
Still openHow much generic retatrutide quality actually varies across sources and whether stacking or switching protocols can be standardized
Nothing here is advice.
I went up to 12 mg of retatrutide with nothing to show except bad bloating. No real drop in hunger or food thoughts. It felt like it helped a bit at first with the smaller amounts but that wore off fast. I only want a modest 5 to 8 kg off and mainly need something to quiet my appetite so I can stick to a reasonable eating plan without constant mental effort. I have a set of tirzepatide, semaglutide, and cagrilintide on hand. Been off retatrutide for two weeks now and plan to test one of these next, maybe adding the amylin one later if needed. Want to start slow, so which should I begin with?
Lots of recent threads show people not impressed with reta, including me. It is a bit annoying to read about folks getting great results on just 2 mg. There is a strong tirz following here, I think you will like it.
I have seen the same pattern of people pushing tirzepatide over the rest. Your note just reinforces that it is likely the better pick for what I need, thanks.
Tirz fan here. Reading what you described, tirz seems like the clear match. Sema tends to bring stronger side effects for a lot of users.
I am one who has responded really well to reta and still does. Never needed more than 3.5 mg a week. My wife dropped 35 lb without going past 2.5 mg a week. Nothing cuts fat like reta when it works for someone.
Did you start straight on tirzepatide or try any of the other GLP-1s first?
Response seems to vary a lot person to person, possibly from genetic differences.
Never pictured myself as part of a cult but I guess I am. Tirz cult member number two here. I really like tirz and still have some reta and cag on hand if I ever want them.
Second thread in an hour where reta is getting criticized. Looks like the trend. I have some as well but will probably never use it. The excitement around it seems to be fading.
I have only used tirz. I keep some reta in the freezer just in case but have not felt any need to open it.
I use both tirz and reta. What puzzles me is users of reta who say it does not quiet food noise. If that is your main goal then go with tirz. I combine them at lower doses to get the upsides of each. It works really well together.
Phase 3 results from Triumph-4 showed 12.2 percent at 9 mg, 18.2 percent at 12 mg, and 4.0 percent on placebo. Some stopped because of side effects.
I switched from reta to tirz. Reta messed me up too much. No sides so far with tirz. Neither one gave me appetite suppression though.
Tirz cult member number three here. It worked great for me and helped with about 90 lb of my total 135 lb loss. I only tried 5 mg for a couple months before losing coverage and stopping, then found this place. Back on 2.5 mg a week with a big stock in the freezer. My wife restarted after childbirth too. I plan to stay on it long term for the other benefits.
Yes, many people get side effects especially at higher doses. Those who keep going do lose weight.
Just took my seventh tirz shot. Like you I have some weight to lose and want to feel better. In six weeks with better food choices and exercise I am down 10 lb. Started at 2.5 for four weeks then went to 3 mg. I want to stay low and maybe add reta later at a low dose to see how they work together. Tirz has already helped a lot with inflammation in my fingers, knees, and feet. Start low and go up slowly to avoid bad sides.
There is a big split between what people report here and what the clinical trials showed, which is strange.
Mine was group tested so that rules out bad product. I even opened a new vial with no change. Maybe there is something different about the generic version but that seems unlikely.
Thanks for sharing your experience.
Just because someone can make reta does not mean it matches the original exactly. There are rumors that the compound itself can differ between makers, which might explain why some get hit hard and others do not. Also your actual dose could be double what you think without testing. Part of the original argument for it being a biologic was their special process.
I agree that is possible even though I know nothing about drug manufacturing.
That is my point exactly. There can be differences even when it tests at high purity. Some versions seem only partly effective or completely useless. Misfolded proteins, storage, and heat all play a role. The number of people getting zero results points to problems with gray-market reta. I am not saying tirz is better overall, just that comparing bad reta to good tirz is not a fair test. One member praised a certain source as the best reta they ever bought. Others report similar differences between sources. Various AI summaries of online reports all call gray reta wildly inconsistent. In one peptide stability chart most brands held up after 90 days but one lost 44 percent while another lost less than 3 percent. They are not all the same.
The top reason people dropped out of the phase 3 reta trials was losing too much weight at the dose they were given.
Almost every complaint online about reta not working comes from people switching from high-dose tirz. For some reason that switch often does not go well. The trials mostly used people new to GLP-1s and it worked very well for them. Gray reta also seems to work well for people new to these drugs. But the ones who started on tirz then switched to reta at a plateau almost always run into trouble.
Over time we will probably see more data on generic GLP-1 quality, especially for retatrutide since it appears the most inconsistent of the group.
If you have tried it, this topic is still open. Sign in to reply — it takes a minute.